NAGE vs REG · P/E 59, rev $61.3M vs P/E 34, rev $1.45B
Niagen Bioscience, Inc. (NAGE) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the NAGE and REG stock pages for the full models.
Not investment advice.